Exploring emerging therapeutic opportunities of druggable enzyme targets involved in type 2 diabetes

Katarina Tomović Pavlović, Andrija Šmelcerović, Marko Anderluh

Open source

DOI
10.1016/j.ejmech.2026.119482
Published
2027-01
Container
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.119482,
  title = {Exploring emerging therapeutic opportunities of druggable enzyme targets involved in type 2 diabetes},
  author = {Katarina Tomović Pavlović and Andrija Šmelcerović and Marko Anderluh},
  year = {2027},
  journal = {European Journal of Medicinal Chemistry},
  doi = {10.1016/j.ejmech.2026.119482},
  url = {https://doi.org/10.1016/j.ejmech.2026.119482}
}

RIS

TY  - JOUR
TI  - Exploring emerging therapeutic opportunities of druggable enzyme targets involved in type 2 diabetes
AU  - Katarina Tomović Pavlović
AU  - Andrija Šmelcerović
AU  - Marko Anderluh
PY  - 2027
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2026.119482
UR  - https://doi.org/10.1016/j.ejmech.2026.119482
ER  - 

APA

Pavlović, K. T., Šmelcerović, A., & Anderluh, M. (2027). Exploring emerging therapeutic opportunities of druggable enzyme targets involved in type 2 diabetes. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2026.119482

Source records